1. Home
  2. DTI vs CNTX Comparison

DTI vs CNTX Comparison

Compare DTI & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Drilling Tools International Corporation

DTI

Drilling Tools International Corporation

HOLD

Current Price

$2.51

Market Cap

68.0M

Sector

Industrials

ML Signal

HOLD

Logo Context Therapeutics Inc.

CNTX

Context Therapeutics Inc.

HOLD

Current Price

$0.47

Market Cap

47.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DTI
CNTX
Founded
1984
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
68.0M
47.7M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
DTI
CNTX
Price
$2.51
$0.47
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$6.60
AVG Volume (30 Days)
224.6K
1.8M
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
17.39
EPS
N/A
N/A
Revenue
$154,446,000.00
N/A
Revenue This Year
$2.05
N/A
Revenue Next Year
$4.48
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.59
N/A
52 Week Low
$1.65
$0.43
52 Week High
$4.69
$3.62

Technical Indicators

Market Signals
Indicator
DTI
CNTX
Relative Strength Index (RSI) 64.96 35.79
Support Level $2.24 $0.43
Resistance Level $2.90 $0.68
Average True Range (ATR) 0.13 0.04
MACD 0.03 0.01
Stochastic Oscillator 84.75 13.66

Price Performance

Historical Comparison
DTI
CNTX

About DTI Drilling Tools International Corporation

Drilling Tools International Corp is an oilfield services company that designs, engineers, and manufactures rental-focused tools used in onshore and offshore horizontal and directional drilling operations, as well as solutions across the well life cycle. It operates through two geographic segments: Western Hemisphere and Eastern Hemisphere. The Western Hemisphere, which generates the majority of revenue, provides downhole drilling tools and rental services for onshore and offshore operations across North America and Latin America, supported by service centers in the U.S. and Canada. The Eastern Hemisphere covers Europe, the Middle East, and Asia-Pacific, where the company offers drilling and well lifecycle solutions through international service centers across the EMEA and APAC regions.

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

Share on Social Networks: